Benzodiazepine inhibition of the stimulation-evoked catecholamine release from bovine adrenomedullary cells in culture.
Effect of benzodiazepines on evoked catecholamine (CA) release from a primary culture of bovine adrenal medullary cells was investigated. Midazolam at high doses (> 10 ? M) inhibited CA release evoked by acetylcholine (ACh), excess K(+) and veratridine but not by A23187 or caffeine in Ca(2+) -free media. Other benzodiazepines, diazepam, clonazepam, nitrazepam and R05-4864, as well as 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide (PK11195) and ethyl-?-carboline-3-carboxylate (?CCE) also inhibited ACh-evoked CA release but only at high concentrations. The inhibitory effect of midazolam on ACh-evoked CA release was not affected by R015-1788, a central-type benzodiazepine receptor antagonist which itself had no effect on basal and ACh-evoked CA release. Facilitatory action of Bay K 8644 on CA release evoked by 20 mM K(+) was reduced by midazolam, PK11195 and R05-4864. Further, ACh-evoked (45)Ca uptake was markedly reduced by midazolam and R05-4864 in association with the inhibition of CA release. These results suggest that benzodiazepines at high doses, inhibit the evoked CA release from adrenal chromaffin cells possibly through the blockade of Ca(2+) influx. Possible involvement of receptor subtypes of benzodiazepines in regulating CA secretion is discussed.